Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease

Author:

Huang Shu‐Yi1,Zhang Ya‐Ru1,Guo Yu1,Du Jing2,Ren Peng3,Wu Bang‐Sheng1,Feng Jian‐Feng345, ,Cheng Wei13456,Yu Jin‐Tai1

Affiliation:

1. Department of Neurology and National Center for Neurological Disorders Huashan Hospital, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science Shanghai Medical College Fudan University Shanghai China

2. Centre for Healthy Brain Ageing (CHeBA) Discipline of Psychiatry and Mental Health School of Clinical Medicine UNSW Sydney New South Wales Australia

3. Institute of Science and Technology for Brain‐Inspired Intelligence Fudan University Shanghai China

4. Key Laboratory of Computational Neuroscience and Brain‐Inspired Intelligence (Fudan University), Ministry of Education Shanghai China

5. Fudan ISTBI—ZJNU Algorithm Centre for Brain‐Inspired Intelligence Zhejiang Normal University Jinhua China

6. Shanghai Medical College and Zhongshan Hospital Immunotherapy Technology Transfer Center Fudan University Shanghai China

Abstract

AbstractINTRODUCTIONAlthough glymphatic function is involved in Alzheimer's disease (AD), its potential for predicting the pathological and clinical progression of AD and its sequential association with core AD biomarkers is poorly understood.METHODSWhole‐brain glymphatic activity was measured by diffusion tensor image analysis along the perivascular space (DTI‐ALPS) in participants with AD dementia (n = 47), mild cognitive impairment (MCI; n = 137), and normal controls (n = 235) from the Alzheimer's Disease Neuroimaging Initiative.RESULTSALPS index was significantly lower in AD dementia than in MCI or controls. Lower ALPS index was significantly associated with faster changes in amyloid positron emission tomography (PET) burden and AD signature region of interest volume, higher risk of amyloid‐positive transition and clinical progression, and faster rates of amyloid‐ and neurodegeneration‐related cognitive decline. Furthermore, the associations of the ALPS index with cognitive decline were fully mediated by amyloid PET and brain atrophy.DISCUSSIONGlymphatic failure may precede amyloid pathology, and predicts amyloid deposition, neurodegeneration, and clinical progression in AD.Highlights The analysis along the perivascular space (ALPS) index is reduced in patients with Alzheimer's disease (AD) dementia, prodromal AD, and preclinical AD. Lower ALPS index predicted accelerated amyloid beta (Aβ) positron emission tomography (PET) burden and Aβ‐positive transition. The decrease in the ALPS index occurs before cerebrospinal fluid Aβ42 reaches the positive threshold. ALPS index predicted brain atrophy, clinical progression, and cognitive decline. Aβ PET and brain atrophy mediated the link of ALPS index with cognitive decline.

Funder

National Natural Science Foundation of China

Shanghai Rising-Star Program

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3